No abstract available
Keywords:
COVID-19; HMG-CoA reductase inhibitor; SARS-CoV; coronavirus infection; statin.
MeSH terms
-
Animals
-
Antiviral Agents / therapeutic use
-
Betacoronavirus
-
COVID-19
-
COVID-19 Drug Treatment
-
Coronavirus Infections / complications
-
Coronavirus Infections / drug therapy*
-
Drug Interactions
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Pandemics
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / drug therapy*
-
Respiratory Distress Syndrome / drug therapy
-
Respiratory Distress Syndrome / virology
-
SARS-CoV-2
Substances
-
Antiviral Agents
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors